-+ 0.00%
-+ 0.00%
-+ 0.00%

MBX BIOSCIENCES INC - TO INITIATE PHASE 3 TRIAL FOR CANVUPARATIDE IN Q3 2026

Reuters·03/09/2026 12:00:01

Please log in to view news